| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc. (FULC) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. FULC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.85M | $33.37M | - | |
| Dir | 469.9K | $1.77M | - | |
| Dir | 36.0K | $135.7K | - | |
| Dir | 36.0K | $135.7K | - | |
| Dir | 36.0K | $135.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2019 | 6 Dimensions Capital, L.P. | 10% Owner | Buy | 118,750 | $16.00 | $1,900,000.00 | +26.9% | |
| Jul 22, 2019 | Levin Mark J | Director, 10% Owner | Buy | 81,250 | $16.00 | $1,300,000.00 | +1.4% |